
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[IOVA] Iovance Biotherapeutics Inc - FCF / Share
Data updated 2024-Nov-17 (Sunday)Note: Detailed Statistics for FCF / Share in Cashflow Statement for Iovance Biotherapeutics Inc [NASDAQ:IOVA] with frequency distribution chart that analyze trends & history . FCF per share is a valuation metric calculated as Free Cash Flow / Shares Outstanding for period. View Cashflow Statement for broader context
Share
Quarterly FCF / Share values for Iovance Biotherapeutics Inc are rounded to enhance readability
2024-Sep | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sep | 2023-Jun | |
---|---|---|---|---|---|---|
FCF / Share | -0.2 | -0.35 | -0.47 | -0.34 | -0.36 | -0.46 |
Sequential Quarter Growth | +42.9% | +25.5% | -38.2% | +5.6% | +21.7% | +6.1% |
Quarter-on Quarter Growth | +44.4% | +23.9% | +4.1% | +30.6% | +12.2% | +11.5% |
Annual FCF / Share values for Iovance Biotherapeutics Inc are rounded to enhance readability
2023-Dec | 2022-Dec | 2021-Dec | 2020-Dec | 2019-Dec | 2018-Dec | |
---|---|---|---|---|---|---|
FCF / Share | -1.63 | -1.97 | -1.73 | -1.82 | -1.33 | -1.05 |
Year-on-Year Growth | +17.3% | -13.9% | +4.9% | -36.8% | -26.7% | +13.9% |
2-yr CAGR | ||||||
3-yr CAGR | ||||||
4-yr CAGR | ||||||
5-yr CAGR |
Frequency distribution of quarterly FCF / Share values from 2011-Jun-30 grouped into buckets. Latest FCF / Share value is -0.2 as of 2024-Sep-30
Subsequent stock performance post earnings date till next announcement for Iovance Biotherapeutics Inc mapped with quarterly FCF / Share values reported at that time. Most recent value denoted with star
Select frequency and calculation type for FCF / Share above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Iovance Biotherapeutics Inc with subsequent post-earnings performance given FCF / Share values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
FCF / Share - Low | 68% | 32% |
FCF / Share - Medium | 38% | 62% |
FCF / Share - High | 47% | 53% |
FCF / Share (Sequential growth %) - Low | 35% | 65% |
FCF / Share (Sequential growth %) - Medium | 56% | 44% |
FCF / Share (Sequential growth %) - High | 65% | 35% |
FCF / Share (QoQ growth %) - Low | 35% | 65% |
FCF / Share (QoQ growth %) - Medium | 84% | 16% |
FCF / Share (QoQ growth %) - High | 40% | 60% |
Related to Iovance Biotherapeutics Inc
Information for Iovance Biotherapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Apr-17 on Google
SEC Reports : Quarterly reports around 2025-Apr-17 on SEC Edgar
Compare Iovance Biotherapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Iovance Biotherapeutics Inc
Industry : Biotechnology industry performance which includes Iovance Biotherapeutics Inc